Utilization of Pneumococcal Vaccine Throughout the University of Pittsburgh Medical Center Health System
Donald B. Middleton, M.D. - Principal Investigator
Funding Agency: Merck PharmaceuticalTotal Project Period: 12/01/99 to 11/30/00
Total Project Award: $35,000
Thousands of people die each year due to pneumococcus. Many hospitalizations for pneumococcus occur in people previously hospitalized for another reason. In this proposal, we will implement standing orders to use pneumococcal vaccines at hospital discharge in UPMC institutions.